Skip Navigation


Cardiovascular Research Advance Access originally published online on October 11, 2007
Cardiovascular Research 2008 77(3):463-470; doi:10.1093/cvr/cvm035
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
77/3/463    most recent
cvm035v2
cvm035v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cai, Z.
Right arrow Articles by Semenza, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cai, Z.
Right arrow Articles by Semenza, G. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007.For permissions please email: journals.permissions@oxfordjournals.org

Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1{alpha}

Zheqing Cai1,2,5, Hua Zhong1,2, Marta Bosch-Marce1,2, Karen Fox-Talbot3, Lei Wang4, Chiming Wei4, Michael A. Trush7 and Gregg L. Semenza1,2,5,6,*

1 Vascular Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
2 McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Suite 671,733 North Broadway, Baltimore, MD 21205, USA
3 Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
4 Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore,MD 21205, USA
5 Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
6 Departments of Pediatrics, Oncology, and Radiation Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
7 Department of Environmental Health Sciences, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD 21205, USA

* Corresponding author. Tel: +1 410 955 1619; fax: +1 443 287 5618. E-mail address: gsemenza{at}jhmi.edu

Aims: We investigated whether hypoxia-inducible factor 1{alpha} (HIF-1{alpha}) plays a role in the acute phase of ischaemic preconditioning (IPC).

Methods and results: Hearts from wild-type (WT) mice and mice heterozygous for a null allele at the locus encoding HIF-1{alpha} (HET) were subjected to IPC (10-min ischaemia/5 min reperfusion, or two cycles of 5 min ischaemia/5 min reperfusion), followed by 30 min ischaemia and reperfusion. Left ventricular-developed pressure, heart rate, and coronary flow rate were measured continuously. Apoptosis and infarct size were assessed by TUNEL assay, cleaved caspase 3 immunohistochemistry, and triphenyltetrazolium chloride staining. Production of reactive oxygen species (ROS) in isolated cardiac mitochondria was measured by a chemiluminescence assay. The phosphatase and tensin homologue (PTEN) and AKT (protein kinase B) were analysed by immunoblot assay. IPC improved functional recovery and limited infarct size and apoptosis after prolonged ischaemia–reperfusion in WT hearts, but not in HET hearts. Mitochondrial ROS production, PTEN oxidation, and AKT phosphorylation were impaired in HET hearts. WT and HET hearts were protected by adenosine, which acts via an ROS-independent mechanism.

Conclusion: HIF-1{alpha} is required for IPC-induced mitochondrial ROS production and myocardial protection against ischaemia–reperfusion injury.

KEYWORDS Hypoxia; Myocardial infarction; Reactive oxygen species


Time for primary review: 33 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
T. Eckle, D. Kohler, R. Lehmann, K. C. El Kasmi, and H. K. Eltzschig
Hypoxia-Inducible Factor-1 Is Central to Cardioprotection: A New Paradigm for Ischemic Preconditioning
Circulation, July 8, 2008; 118(2): 166 - 175.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Oshima, N. Ouchi, K. Sato, Y. Izumiya, D. R. Pimentel, and K. Walsh
Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the Heart
Circulation, June 17, 2008; 117(24): 3099 - 3108.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Schulz and G. Heusch
Extracellular Adenosine Attenuates Left Ventricular Hypertrophy Through Its Impact on the Protein Kinase and Phosphatase Interaction
Hypertension, June 1, 2008; 51(6): 1474 - 1475.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Ytrehus
Hypoxia-inducible factor 1{alpha}: a new piece in the preconditioning puzzle
Cardiovasc Res, February 1, 2008; 77(3): 443 - 444.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.